SESSION 2

HOW THE JOURNEY BEGINS

J.J. Kiladjian, A. Reiter

9:30 - 9:35

Introduction by the chair

9:35 - 10:05

Chronic inflammation and mut. acquisition

H. Hasselbalch

10:05 - 10:35

Mut. allele burden and its clinical relevance

R. Skoda

10:35 - 10:55

Discussion about clinical relevance

all

10:55 - 11:30

BREAK

SESSION 3

HOW THE JOURNEY CONTINUES …

M. Doubek, M. Egyed

11:30 - 11:35

Introduction by the chair

11:35 - 12:00

Management of pediatric patients

N. Kucine

12:00 - 12:25

Management of young adult patients

M. Sobas

12:25 - 13:30

BREAK

13:30 - 13:55

From low-risk to high-risk

A. Reiter

13:55 - 14:20

How I treat PV

H. Gisslinger

14:20 - 14:45

MF

F. Passamonti

14:45 - 15:10

MDS

S. De Botton

15:10 - 15:45

BREAK

SESSION 4

COMORBIDITIES & DRUG TOXICITIES – HOW TO HANDLE – PANEL DISCUSSION

M. Griesshammer, H Gisslinger

15:45 - 15:50

Introduction by the chair

15:50 - 16:10

Impulse lecture

R. Silver

16:10 - 17:10

Panel discussion

A. Hatalova, H. Gisslinger A. Luger, V. Buxhofer-Ausch

Kindly supported by AOP Health